August 15, 2022
By Daniel E. Kremens, MD, JD
Despite the availability of medications to relieve OFF episodes in Parkinson disease, widespread adoption of on-demand therapies has been less-than-ideal, marking the need to shift the treatment paradigm in PD.
August 15, 2022
By NeurologyLive® Staff
Here's some of what is coming soon to NeurologyLive® this week.
August 14, 2022
By Marco Meglio
After failing to show statistical significance in a cohort of children, teriflunomide, the disease-modifying medication observed in the analysis, had compelling evidence to suggest it was efficacious in that age group following the Bayesian approach to analysis.
August 14, 2022
By Matt Hoffman
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is multiple sclerosis.
August 13, 2022
By Marco Meglio
Vesna Garovic, MD, PhD, chair of the nephrology division at Mayo Clinic, discussed the appropriate reaction to data suggesting late-life elevated inflammation and neurovascular damage from severe preeclampsia.
Shifting the Paradigm: Earlier Use of On-Demand Therapy for Treating OFF Time in Parkinson Disease
Using Virtual Reality to Identify Early Signs of Parkinson Disease: Jay Alberts, PhD
Raising the Awareness of Severe Preeclampsia and Recognizing Potential Long-Term Impacts
What Proactive Semantic Interference and Persistent PSI Can Reveal About Cognitive Status: Rosie Curiel, PsyD